Variant report
Variant | esv3496084 |
---|---|
Chromosome Location | chr8:104014081-104014609 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AZIN1-2 | chr8:104014108-104014651 | NONHSAT128138 |
2 | lnc-KB-1507C5.2.1-2 | chr8:104011293-104014653 | NONHSAT128145 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561286935 | chr8:104014104-104014105 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs200703982 | chr8:104014106-104014107 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs79172352 | chr8:104014107-104014108 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs545340685 | chr8:104014112-104014113 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs113216010 | chr8:104014116-104014117 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs190554054 | chr8:104014145-104014146 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs573086754 | chr8:104014173-104014174 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs540454494 | chr8:104014176-104014177 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs565145752 | chr8:104014180-104014181 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs532656475 | chr8:104014188-104014189 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs181779128 | chr8:104014195-104014196 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs553352349 | chr8:104014252-104014253 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs368111297 | chr8:104014255-104014256 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs186899460 | chr8:104014271-104014272 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs567591614 | chr8:104014277-104014278 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs113307807 | chr8:104014313-104014314 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | mRNA abundance |
17 | rs546829912 | chr8:104014339-104014340 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs191322378 | chr8:104014356-104014357 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs577704 | chr8:104014359-104014360 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs11988081 | chr8:104014370-104014371 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs575167191 | chr8:104014380-104014381 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs535878808 | chr8:104014388-104014389 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs561822599 | chr8:104014418-104014419 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs151251374 | chr8:104014426-104014427 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs554821586 | chr8:104014437-104014438 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs140494148 | chr8:104014438-104014439 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs150022556 | chr8:104014446-104014447 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs565148481 | chr8:104014487-104014488 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs579324 | chr8:104014522-104014523 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs2935582 | chr8:104014549-104014550 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs72667301 | chr8:104014573-104014574 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs2945830 | chr8:104014574-104014575 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Breast cancer | 20409316 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Breast cancer | 21611746 | CNVD |
Oral squamous cell carcinoma | 21853135 | CNVD |
Bladder cancer | 21909424 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:104007200-104014400 | Weak transcription | Primary B cells from peripheral blood | blood |
2 | chr8:104007600-104014200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr8:104011800-104014200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr8:104012800-104014200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr8:104012800-104014600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr8:104013000-104014200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr8:104013000-104014400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr8:104013400-104017400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
9 | chr8:104013600-104015000 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
10 | chr8:104014000-104014200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr8:104014000-104014200 | Flanking Active TSS | HepG2 | liver |
12 | chr8:104014000-104015200 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |
13 | chr8:104014200-104014400 | Enhancers | H1 Cell Line | embryonic stem cell |
14 | chr8:104014200-104014400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |